Investor
Relations

October 7, 2026

Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2

September 21, 2026

Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day

September 17, 2026

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026